The Association Between HbA1c and 1-Year Diabetes-Related Medical Costs: A Retrospective Claims Database Analysis

por Boye, Kristina S., Lage, Maureen J., Thieu, Vivian T.
Publicado 2022

Treatment and prevention of severe hypoglycaemia in people with diabetes: Current and new formulations of glucagon

por Thieu, Vivian T., Mitchell, Beth D., Varnado, Oralee J., Frier, Brian M.
Publicado 2020

The Burden of Type 2 Diabetes and the Value of Achieving Near Normoglycemia from the Patient Perspective

por Gelhorn, Heather, Balantac, Zaneta, Shinde, Shraddha, Thieu, Vivian Thuyanh, Boye, Kristina S.
Publicado 2021

Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review

por Boye, Kristina S, Shinde, Shraddha, Kennedy-Martin, Tessa, Robinson, Susan, Thieu, Vivian T
Publicado 2022

The Association Between Sustained HbA1c Control and Long-Term Complications Among Individuals with Type 2 Diabetes: A Retrospective Study

por Boye, Kristina S., Thieu, Vivian T., Lage, Maureen J., Miller, Heather, Paczkowski, Rosirene
Publicado 2022

Trends in HbA1c and Body Mass Index Among Individuals with Type 2 Diabetes: Evidence from a US Database 2012–2019

por Boye, Kristina S., Lage, Maureen J., Shinde, Shraddha, Thieu, Vivian, Bae, Jay Patrick
Publicado 2021

Tirzepatide as Monotherapy Improved Markers of Beta-cell Function and Insulin Sensitivity in Type 2 Diabetes (SURPASS-1)

por Lee, Clare J, Mao, Huzhang, Thieu, Vivian T, Landó, Laura Fernández, Thomas, Melissa K
Publicado 2023

Patient preferences for glucagon-like peptide 1 receptor–agonist treatment attributes

por Thieu, Vivian T, Robinson, Susan, Kennedy-Martin, Tessa, Boye, Kristina S, Garcia-Perez, Luis-Emilio
Publicado 2019

The Benefits of Safely Achieving Near Normoglycemia from the Perspective of People with Type 2 Diabetes: A Quantitative Survey Study

por Gelhorn, Heather L, Ross, Melissa M, Shinde, Shraddha, Thieu, Vivian Thuyanh, Boye, Kristina S
Publicado 2022

The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes

por Boye, Kristina S., Ford, Janet H., Thieu, Vivian T., Lage, Maureen J., Terrell, Kendra A.
Publicado 2023

Improved Glycaemic and Weight Management Are Associated with Better Quality of Life in People with Type 2 Diabetes Treated with Tirzepatide

por Boye, Kristina S., Sapin, Hélène, Dong, Wenxiu, Williamson, Suzanne, Lee, Clare J., Thieu, Vivian Thuyanh
Publicado 2023

Decision-Making and Relationship Competence When Reporting Suspected Physical Abuse and Child Neglect: An Objective Structured Clinical Evaluation

por Tufford, Lea, Lee, Barbara, Bogo, Marion, Wenghofer, Elizabeth, Etherington, Cassandra, Thieu, Vivian, Zhao, Rose
Publicado 2021

OR03-1 Achievement of HbA1c <6.5% without weight gain and hypoglycemia in people with type 2 diabetes treated with tirzepatide across the phase 3 SURPASS program

por Allen, Sheryl Elaine, Cheng, Alice, Choudhary, Pratik, Levine, Joshua A, Ranta, Kari, Thieu, Vivian Thuyanh, Valderas, Elisa Gomez, Lingvay, Ildiko
Publicado 2022

Effect of once weekly dulaglutide by baseline beta‐cell function in people with type 2 diabetes in the AWARD programme

por Mathieu, Chantal, Del Prato, Stefano, Botros, Fady T., Thieu, Vivian T., Pavo, Imre, Jia, Nan, Haupt, Axel, Karanikas, Chrisanthi A., García‐Pérez, Luis‐Emilio
Publicado 2018

Effect of once‐weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c

por Gallwitz, Baptist, Dagogo‐Jack, Samuel, Thieu, Vivian, Garcia‐Perez, Luis‐Emilio, Pavo, Imre, Yu, Maria, Robertson, Kenneth E., Zhang, Nan, Giorgino, Francesco
Publicado 2017

Patient-Reported Outcomes in People with Type 2 Diabetes Receiving Tirzepatide in the SURPASS Clinical Trial Programme

por Boye, Kristina S., Thieu, Vivian Thuyanh, Sapin, Hélène, Lee, Clare J., Landó, Laura Fernández, Brown, Katelyn, Bray, Ross, Wiese, Russell J., Patel, Hiren, Rodríguez, Ángel, Yu, Maria
Publicado 2023